• 1.中科院蘭州化學物理研究所（蘭州730000）;;
  • 2.蘭州醫(yī)學院第一附屬醫(yī)院普外科（蘭州730000）;

目的 探討環(huán)氧合酶2（COX2）在胃癌組織中的表達及其臨床意義。方法應(yīng)用SP免疫組織化學方法檢測47例胃癌及16例正常胃組織中COX2的表達及其與幽門螺桿菌在胃癌組織中感染的關(guān)系。結(jié)果正常胃組織中未見COX2表達，胃癌組織中COX2表達陽性率為63.8%（30/47），其陽性表達與腫瘤的TNM分期及淋巴結(jié)轉(zhuǎn)移相關(guān)（P＜0.01），幽門螺桿菌感染陽性組中COX2表達陽性率為72.4%（21/29），顯著高于幽門螺桿菌陰性組的50.0%（9/18），P=0.02。結(jié)論COX2的表達參與胃癌的發(fā)生及惡性進展，COX2的檢測有助于評價胃癌的生物學行為。

引用本文： 李玉民,薛群基,周彥明,石斌,李汛,柴琛,周文策. 胃癌組織中環(huán)氧合酶-2的表達及其意義△. 中國普外基礎(chǔ)與臨床雜志, 2003, 10(2): 137-139. doi: 復制

1. Zimmermann KC,Sarbia M,Weber AA,et al.Cyclooxygenase2 expression in human esophageal carcinoma [J].Cancer Res,1999; 59（1）∶198.
2. 胡伏蓮，周殿元，賈博琦主編.幽門螺桿菌感染的基礎(chǔ)與臨床 [M].第3版.北京： 中國科學技術(shù)出版社，2000∶299～299.
3. 莊則豪，王立東.非甾體類抗炎藥與消化道腫瘤 [J].世界華人消化雜志，2001； 9（9）∶1050.
4. 孫波，吳云林，張學軍，等.舒林酸抑制人胃腺癌細胞增殖及誘導凋亡 [J].世界華人消化雜志，2001； 9（9）∶997.
5. Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells [J].Cell,1998; 93（5）∶705.
6. Tomozawa S,Nagawa H,Tsuno N,et al.Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX2 inhibitor,JTE522 [J].Br J Cancer,1999; 81（8）∶1274.
7. Sheehan KM,Sheahan K,O’Donoghue DP,et al.The relationship between cyclooxygenase2 expression and colorectal cancer [J].JAMA,1999; 282(13)∶1254.
8. Ristimaki A,Honkanen N,Jankala H,et al.Expression cyclooxygenase2 in human gastric carcinoma [J].Cancer Res,1997; 57(7)∶1276.
9. 胡伏蓮，周殿元，賈博琦主編.幽門螺桿菌感染的基礎(chǔ)與臨床 [M].第3版. 北京： 中國科學技術(shù)出版社， 2000∶210~221.
10. Hack HM,Fennerty MB,Sampliner R,et al.Apprent reverse of intestinal metaplasia after treatment of H.pylori infection [J].Gastroenterology,1994; 106(4)∶A87.
11. Borody TJ,Clark IW,Andrews P,et al.Eradication of Helicobacter pylori may not reverse severe gastric dysplasia [J].Am J Gastroenterol,1995; 90(3)∶498.
12. McCarthy CJ,Crofford LJ,Greenson J,et al.Cyclooxygenase2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection [J].Am J Gastroenterol,1999; 94(5)∶1218.
  1. 1. Zimmermann KC,Sarbia M,Weber AA,et al.Cyclooxygenase2 expression in human esophageal carcinoma [J].Cancer Res,1999; 59（1）∶198.
  2. 2. 胡伏蓮，周殿元，賈博琦主編.幽門螺桿菌感染的基礎(chǔ)與臨床 [M].第3版.北京： 中國科學技術(shù)出版社，2000∶299～299.
  3. 3. 莊則豪，王立東.非甾體類抗炎藥與消化道腫瘤 [J].世界華人消化雜志，2001； 9（9）∶1050.
  4. 4. 孫波，吳云林，張學軍，等.舒林酸抑制人胃腺癌細胞增殖及誘導凋亡 [J].世界華人消化雜志，2001； 9（9）∶997.
  5. 5. Tsujii M,Kawano S,Tsuji S,et al.Cyclooxygenase regulates angiogenesis induced by colon cancer cells [J].Cell,1998; 93（5）∶705.
  6. 6. Tomozawa S,Nagawa H,Tsuno N,et al.Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX2 inhibitor,JTE522 [J].Br J Cancer,1999; 81（8）∶1274.
  7. 7. Sheehan KM,Sheahan K,O’Donoghue DP,et al.The relationship between cyclooxygenase2 expression and colorectal cancer [J].JAMA,1999; 282(13)∶1254.
  8. 8. Ristimaki A,Honkanen N,Jankala H,et al.Expression cyclooxygenase2 in human gastric carcinoma [J].Cancer Res,1997; 57(7)∶1276.
  9. 9. 胡伏蓮，周殿元，賈博琦主編.幽門螺桿菌感染的基礎(chǔ)與臨床 [M].第3版. 北京： 中國科學技術(shù)出版社， 2000∶210~221.
  10. 10. Hack HM,Fennerty MB,Sampliner R,et al.Apprent reverse of intestinal metaplasia after treatment of H.pylori infection [J].Gastroenterology,1994; 106(4)∶A87.
  11. 11. Borody TJ,Clark IW,Andrews P,et al.Eradication of Helicobacter pylori may not reverse severe gastric dysplasia [J].Am J Gastroenterol,1995; 90(3)∶498.
  12. 12. McCarthy CJ,Crofford LJ,Greenson J,et al.Cyclooxygenase2 expression in gastric antral mucosa before and after eradication of Helicobacter pylori infection [J].Am J Gastroenterol,1999; 94(5)∶1218.